Market Research Logo

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease)
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Ankylosing Spondylitis (Bekhterev's Disease) and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Ankylosing Spondylitis (Bekhterev's Disease) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease)
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Ankylosing Spondylitis (Bekhterev's Disease) Overview
Therapeutics Development
Pipeline Products for Ankylosing Spondylitis (Bekhterev's Disease) - Overview
Pipeline Products for Ankylosing Spondylitis (Bekhterev's Disease) - Comparative Analysis
Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics under Development by Companies
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Ankylosing Spondylitis (Bekhterev's Disease) - Products under Development by Companies
Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development
Amgen Inc.
Avesthagen Limited
BIOCAD
Biocon Limited
Bionovis SA
Boehringer Ingelheim GmbH
Celgene Corporation
Celltrion, Inc.
Coherus BioSciences, Inc.
Epirus Biopharmaceuticals, Inc.
Genor BioPharma Co., Ltd.
Hetero Drugs Limited
Inbiopro Solutions Pvt. Ltd.
Innovent Biologics, Inc.
Johnson & Johnson
Lupin Limited
Mabion SA
Mabtech Limited
Momenta Pharmaceuticals, Inc.
Mycenax Biotech Inc.
Novartis AG
Oncobiologics, Inc.
Panacea Biotec Limited
Pfizer Inc.
Protalix BioTherapeutics, Inc.
Sandoz International GmbH
Shanghai Pharmaceutical Co., Ltd.
Therapeutic Proteins International, LLC
Vitae Pharmaceuticals, Inc.
Xbrane Bioscience AB
Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
adalimumab biosimilar - Drug Profile
apremilast - Drug Profile
BI-655066 - Drug Profile
certolizumab pegol biosimilar - Drug Profile
COVA-322 - Drug Profile
DNX-114 - Drug Profile
DNX-514 - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
etanercept biosimilar - Drug Profile
golimumab - Drug Profile
golimumab biosimilar - Drug Profile
golimumab biosimilar - Drug Profile
golimumab biosimilar - Drug Profile
IBI-303 - Drug Profile
IBPM-004AM - Drug Profile
IBPM-005IX - Drug Profile
infliximab biobetter - Drug Profile
infliximab biosimilar - Drug Profile
infliximab biosimilar - Drug Profile
infliximab biosimilar - Drug Profile
infliximab biosimilar - Drug Profile
infliximab biosimilar - Drug Profile
INV-17 - Drug Profile
secukinumab - Drug Profile
thalidomide - Drug Profile
tofacitinib - Drug Profile
VTP-43742 - Drug Profile
Ankylosing Spondylitis (Bekhterev's Disease) - Recent Pipeline Updates
Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects
Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products
Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H2 2015
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease) - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd...1)
Number of Products under Development by Companies, H2 2015 (Contd...2)
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd...1)
Products under Development by Companies, H2 2015 (Contd...2)
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Avesthagen Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by BIOCAD, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Boehringer Ingelheim GmbH, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corporation, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celltrion, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co., Ltd., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Hetero Drugs Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Johnson & Johnson, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Lupin Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mabion SA, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mabtech Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Panacea Biotec Limited, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Pfizer Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co., Ltd., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Therapeutic Proteins International, LLC, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Vitae Pharmaceuticals, Inc., H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Bioscience AB, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics - Recent Pipeline Updates, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects (Contd...1), H2 2015
Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H2 2015
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease) - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report